PROCESS FOR PRODUCING A HUMAN T-CELL POPULATION HAVING BOTH CYTOTOXIC AND IMMUNOSUPPRESSIVE ACTIVITIES
    2.
    发明申请
    PROCESS FOR PRODUCING A HUMAN T-CELL POPULATION HAVING BOTH CYTOTOXIC AND IMMUNOSUPPRESSIVE ACTIVITIES 有权
    生产具有两种细胞因子和免疫抑制活性的人类T细胞群体的方法

    公开(公告)号:US20120040454A1

    公开(公告)日:2012-02-16

    申请号:US13265942

    申请日:2010-04-15

    IPC分类号: C12N5/0783

    摘要: The present invention has an object to provide a method for efficiently producing a human T cell population which has both cytotoxic and immunosuppressive activities, and solves the above object by providing a method for producing a human T cell population which has both cytotoxic and immunosuppressive activities, comprising the following steps (1) to (4):(1) fractionating mononuclear cells collected from a human umbilical cord blood into CD14-positive (CD14+) cells and CD14-negative (CD14−) cells, and then fractionating the CD14-negative (CD14−) cells into CD2-positive CD14-negative (CD2+CD14−) cells, and CD2-negative CD14-negative (CD2−CD14−) cells;(2) co-culturing the CD2-positive CD14-negative (CD2+CD14−) cells obtained in step (1) with stromal cells to generate blast cells;(3) adding the blast cells obtained in step (2) to the co-culture of the CD14-positive (CD14+) cells obtained in step (1) with stromal cells to allow the blast cells to proliferate; and(4) allowing the blast cells obtained in step (3) to further proliferate by co-culturing with stromal cells in the presence of interleukin-2 (IL-2) to generate a human T cell population which has both cytotoxic and immunosuppressive activities.

    摘要翻译: 本发明的目的是提供一种有效地制备具有细胞毒性和免疫抑制活性的人T细胞群的方法,通过提供具有细胞毒性和免疫抑制活性的人T细胞群的制备方法来解决上述目的, 包括以下步骤(1)至(4):(1)将从人脐带血中收集的单核细胞分离成CD14阳性(CD14 +)细胞和CD14阴性(CD14-)细胞,然后将CD14阴性 (CD14-)细胞进入CD2阳性CD14阴性(CD2 + CD14-)细胞和CD2阴性CD14阴性(CD2-CD14-)细胞; (2)在步骤(1)中获得的CD2阳性CD14-阴性(CD2 + CD14-)细胞与基质细胞共培养以产生胚细胞; (3)将步骤(2)中获得的胚细胞添加到步骤(1)中获得的CD14阳性(CD14 +)细胞与基质细胞的共培养物中,以使胚细胞增殖; 和(4)通过在白细胞介素-2(IL-2)存在下与基质细胞共培养使得步骤(3)中获得的胚细胞进一步增殖以产生具有细胞毒性和免疫抑制活性的人T细胞群 。

    NOVEL HUMAN T-CELL POPULATION
    3.
    发明申请
    NOVEL HUMAN T-CELL POPULATION 有权
    新人类T细胞人口

    公开(公告)号:US20090297490A1

    公开(公告)日:2009-12-03

    申请号:US12282977

    申请日:2007-03-15

    IPC分类号: A61K35/12 C12N5/08

    摘要: The present invention has objects to provide a novel human T-cell population having both cytotoxic and immunosuppressive activities, and to a method for preparing the same. The above objects are attained by providing a human T-cell population which is obtainable by coculturing mononuclear cells, collected from human blood, with stroma cells and which has the following features: (1) being positive for CD3, CD25, CD28 and T-cell antigen receptor αβ; (2) essentially consisting of three groups of a CD4 positive and CD8 positive (CD4+CD8−) T-cell group, a CD4 positive and CD8 dimly positive (CD4+CD8dim) T-cell group, and a CD4 negative and CD8 positive (CD4−CD8+) T-cell group; (3) exerting a cytotoxic activity against the cocultured stroma cells; and (4) exerting an immunosuppressive activity against activated T cells.

    摘要翻译: 本发明的目的是提供具有细胞毒性和免疫抑制活性两者的新型人T细胞群及其制备方法。 上述目的是通过提供通过共培养从人血液收集的单核细胞与基质细胞获得的人类T细胞群而获得的,并且具有以下特征:(1)对于CD3,CD25,CD28和T- 细胞抗原受体 (2)基本上由CD4阳性和CD8阳性(CD4 + CD8-)T细胞组,CD4阳性和CD8阳性(CD4 + CD8dim)T细胞组和CD4阴性和CD8阳性三组组成 (CD4-CD8 +)T细胞组; (3)对共培养的基质细胞发挥细胞毒活性; 和(4)对活化的T细胞施加免疫抑制活性。

    Human T-cell population
    4.
    发明授权
    Human T-cell population 有权
    人类T细胞群体

    公开(公告)号:US08883495B2

    公开(公告)日:2014-11-11

    申请号:US12282977

    申请日:2007-03-15

    摘要: The present invention has objects to provide a novel human T-cell population having both cytotoxic and immunosuppressive activities, and to a method for preparing the same. The above objects are attained by providing a human T-cell population which is obtainable by coculturing mononuclear cells, collected from human blood, with stroma cells and which has the following features: (1) being positive for CD3, CD25, CD28 and T-cell antigen receptor αβ; (2) essentially consisting of three groups of a CD4 positive and CD8 positive (CD4+CD8+) T-cell group, a CD4 positive and CD8 dimly positive (CD4+CD8dim) T-cell group, and a CD4 negative and CD8 positive (CD4−CD8+) T-cell group; (3) exerting a cytotoxic activity against the cocultured stroma cells; and (4) exerting an immunosuppressive activity against activated T cells.

    摘要翻译: 本发明的目的是提供具有细胞毒性和免疫抑制活性两者的新型人T细胞群及其制备方法。 上述目的是通过提供通过共培养从人血液收集的单核细胞与基质细胞获得的人类T细胞群而获得的,并且具有以下特征:(1)对于CD3,CD25,CD28和T- 细胞抗原受体α&bgr; (2)基本上由CD4阳性和CD8阳性(CD4 + CD8 +)T细胞组,CD4阳性和CD8阳性(CD4 + CD8dim)T细胞组和CD4阴性和CD8阳性(CD4 + CD4-CD8 +)T细胞组; (3)对共培养的基质细胞发挥细胞毒活性; 和(4)对活化的T细胞施加免疫抑制活性。

    Key switch device and keyboard
    9.
    发明授权
    Key switch device and keyboard 有权
    钥匙开关装置和键盘

    公开(公告)号:US08779308B2

    公开(公告)日:2014-07-15

    申请号:US13367752

    申请日:2012-02-07

    摘要: A key switch device including a key top; a pair of link members connected to the key top and interlocked with each other to guide a vertical motion of the key top; a switch mechanism including a membrane sheet switch capable of opening and closing a contact section of an electrical circuit in accordance with the vertical motion of the key top; a flexible thin film sheet attached to the membrane sheet switch; and a housing attached to the thin film sheet, the housing adapted to connect the link members to the thin film sheet.

    摘要翻译: 一种钥匙开关装置,包括键顶; 一对连接构件,连接到键顶并互锁,以引导键顶的垂直运动; 开关机构,其包括根据键顶的垂直运动能够打开和闭合电路的接触部分的膜片开关; 安装在薄片开关上的柔性薄膜片; 以及附接到所述薄膜片的壳体,所述壳体适于将所述连接构件连接到所述薄膜片。